Popular Articles

FluoroPharma To Present Phase I Study Results Of Novel Positron Emission Tomography (PET) Myocardial Perfusion Imaging (MPI) Tracer
FluoroPharma Inc., a company developing breakthrough PET molecular imaging agents, announced that it will present Phase I data relating to the safety, dosimetry, and pharmacokinetics in human subjects of BFPET, its novel 18-F labeled PET tracer for myocardial perfusion imaging, at the Society of Nuclear Medicine 2009 Annual Meeting in Toronto.

Recession-Battered States Cut Funding For Health Services
Under economic pressure, states are slashing funding for health services from Connecticut to California. The cuts frustrate providers and lawmakers are looking for ways to limit harm.
News of the day
University Of Pittsburgh Schools Of The Health Sciences Announce New Research Funding
Innovative research conducted by faculty of the University of Pittsburgh Schools of the Health Sciences contributes to a better understanding of the causes and origins of disease and aids in the development of more effective treatment approaches. Government and private-sector funding is critical to this process of scientific inquiry. The following projects recently have been awarded grants that will enable the continuation of existing projects or the pursuit of new areas of investigation:
Mental Health

Memory Impairment Predicts Alzheimer's Disease

Self perceived memory impairment is an indicator of pending Alzheimer dementia but not of vascular dementia, according to results of the LADIS (Leukoaraiosis and Disability) study which explores the impact of brain white matter changes on the functioning of independent elderly individuals over a 3 year period. The study is being presented at the current meeting of the European Neurological Society (ENS), a major meeting in European neurology that is gathering more than 2,900 experts from all over the world in Milan. "The LADIS study examines brain white matter changes and their influence on the intellectual and motor abilities of aging people," noted Professor Franz Fazekas (Department of Neurology, Medical University Graz, Austria), one of the leading LADIS researches. The study involved medical centres in eleven countries. The analysis being presented in Milan covered 639 persons and their subjective complaints of memory dysfunction. After three years, 90 patients had become demented. Of those, there were 34 cases classified as Alzheimer dementia with vascular component, 54 had vascular dementia and 2 frontotemporal dementia. Another 147 patients showed some cognitive impairment but not dementia. "Interestingly memory complaints showed quite different associations with dementia subtypes" stated Professor Fazekas. "Self-perceived memory impairment was a predictor of Alzheimer dementia with vascular component, independent of other risk factors, but not a predictor of vascular dementia." Abstract: ENS abstract O153: Verdelho et al, Self-perceived memory impairment predict Alzheimer"s disease but not vascular dementia in independent elderly with white matter changes. Results from the LADIS study. European Neurological Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):